Questionable recommendations for cholinesterase inhibitor use in AD

By  

Inpharma, Vol. 1, Iss. 1500, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

By Mustazza C.   Borioni A.   Giudice M.R.D.   Gatta F.   Ferretti R.   Meneguz A.   Volpe M.T.   Lorenzini P.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 2, 2002-02 ,pp. : 91-109

Elsevier

Access to resources Recommend Favorite

Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine

By Wang R.-H.   Schorer-Apelbaum D.   Weinstock M.  

European Journal of Pharmacology, Vol. 433, Iss. 1, 2001-12 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Influence of Cholinesterase Inhibitor on Clinical Symptoms of Schizophrenia

By  

Current Psychopharmacology, Vol. 6, Iss. 1, 2017-04 ,pp. : 27-35

Bentham Science Publishers

Access to resources Recommend Favorite

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M.   Noble S.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite